From Monotherapy to Multi-Drug Regimens: Metformin's Role as the Therapeutic Backbone for Over Seven Decades Written By Dr. RITESH KU. AGRAWALA12 Jun 2026 10:41 AM ISTFor over seven decades, metformin has remained the cornerstone of T2DM management as monotherapy and in combination with other glucose-lowering...
Dapagliflozin and Metformin in T2D: Three Important Indian Evidences Revisited- Dr Semanti Chakraborty Written By Dr. Semanti Chakraborty10 Jun 2026 11:09 AM ISTIndia's Type 2 diabetes(T2D) prevalence is increasing, with over half of affected individuals remaining undiagnosed. More than 70% of Indian T2D...
Orbit of Care in Indian T2D with CV Risk: Practice Update & Spotlight on Smart Application of Dapagliflozin & Sitagliptin FDC Written By Dr Manoj Chawla4 Jun 2026 10:56 AM ISTIn India, type 2 diabetes(T2D) clusters with cardiovascular risk and earlier age than in Western populations, mainly driven by visceral adiposity...
Addition of Metformin to SGLT2 Inhibitors Lowers Kidney Disease Risk in Diabetes Patients: Study Written By Dr Riya Dave14 March 2025 9:00 AM ISTResearchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a significant reduction in...
